SCHEMBL18995043

SCHEMBL18995043

N#Cc1cc(Nc2ncc(F)c(N)n2)ccc1N1CCN(C2COC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 19/20 0.55
▸ JAK2 O60674 9/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19527758 0.83 NPC1 (0.46) TBK1JAK2
SCHEMBL18994991 0.83 NPC1 (0.47) TBK1JAK2
SCHEMBL19836466 0.82 CDK4 (0.51) TBK1JAK2
SCHEMBL18995151 0.80 BRD4 (0.48) TBK1JAK2
SCHEMBL17631785 0.80 TBK1 (0.64) TBK1JAK2
SCHEMBL18995035 0.80 CSF1R (0.40) TBK1JAK2
SCHEMBL15337260 0.77 TBK1 (0.46) TBK1JAK2
SCHEMBL19527807 0.77 TBK1 (0.46) TBK1JAK2
SCHEMBL17631378 0.76 TBK1 (0.77) TBK1JAK2
SCHEMBL2551874 0.75 CSF1R (0.56) JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682976-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-06-20 — — US disclosed
Send feedback